INmune Bio receives MHRA alignment for RDEB therapy filing
INmune Bio receives MHRA alignment for RDEB therapy filing
INmune Bio receives MHRA alignment for RDEB therapy filing
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.